CTT Pharmaceutical Holdings, Inc. (CTTH)

Market Cap	3.58M +83.6%
Revenue (ttm)	n/a
Net Income	-211.04K
EPS	-0.00
Shares Out	58.71M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	0.0610
Previous Close	0.0660
Day's Range	0.0610 - 0.0610
52-Week Range	0.0253 - 0.1000
Beta	0.72
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 28, 2026

About CTTH

CTT Pharmaceutical Holdings, Inc. engages in the development of oral drug delivery systems for pain management and treatment. It focuses on fast dissolving drug delivery systems. The company’s technology platform includes the development of advanced oral delivery thin wafers infused with both natural and/or synthetic cannabis extracts to deliver treatment as an alternate to smoking and ingestion. Its principal asset is a patented orally administered dissolvable strip. The company is based in Tampa, Florida.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• CEO: Ryan Khouri
• Employees: 1
• Stock Exchange: OTCMKTS
• Ticker Symbol: CTTH

Financial Performance

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Jul 27, 2026

Data Sources Report a data error